Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

130.62
Delayed Data
As of May 27
 +2.75 / +2.15%
Today’s Change
51.93
Today|||52-Week Range
132.99
+34.66%
Year-to-Date

Today’s Trading

Previous close127.87
Today’s open128.06
Day’s range127.00 - 131.74
Volume829,023
Average volume (3 months)715,297
Market cap$10.8B
Dividend yield--
Data as of 4:00pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+38.24%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book10.54

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+1.25+1.80%
ISISIsis Pharmaceuticals...+0.73+1.09%
ICLRICON PLC+0.56+0.86%
DYAXDyax Corp+0.52+1.98%
Data as of 4:04pm ET, 05/27/2015

Financials

Next reporting dateAugust 3, 2015
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers